New treatment option for children with cholera

November 28, 2002

Results of a study in this week's issue of THE LANCET suggest that the antibiotic azithromycin could be an effective treatment option for children with cholera.

Cholera is a major public-health problem which is greatly under-reported; children are most affected by this bacterial disease which causes severe diarrhoea resulting in dehydration. Around 5000 deaths from cholera were reported to the WHO in 2000, probably a severe underestimate as Bangladesh--where over 200,000 people are infected with the cholera bacterium--has not supplied WHO with data relating to cholera illness or death.

Effective single-dose antibiotics have only been identified for adults with cholera; single-dose regimens are especially desirable for children to increase compliance. Wasif Khan from the Centre for Health and Population Research, Dhaka, Bangladesh, and colleagues did a randomised study of 128 severely dehydrated children with cholera, treated at one of two treatment centres in Bangladesh in 1999. Children were assigned either single-dose azithromycin (20 mg/kg bodyweight or 12·5 mg/kg erythromycin every six hours for 3 days.

Although treatment success was similar in both groups, children given azithromycin had reduced duration of diarrhoea compared with those given erythromycin--24 hours compared with 42 hours, respectively. Vomiting was also reduced in children given azithromycin (one case compared with four cases in the erythromycin group).

The investigators comment how cost may be the real issue affecting future drug treatment of childhood cholera--azithromycin is five times more expensive than co-trimoxazole and 50% more expensive than erythromycin.

Wasif A Khan comments: "Whether or not the potential advantages of single-dose azithromycin--increased compliance, simplified logistics, reduction in vomiting--justify the additional cost when compared with other drug regimens is a decision that individual treatment centres involved in the care of children with cholera will have to make."
-end-
Contact:
Mr Wasif A Khan, Clinical Science Division, ICDDRB, Centre for Health and Population Research, GPO Box 128, Dhaka-1000, Bangladesh;
T)880-2-988-6734;
F)880-2-882-3116;
E) wakhan@icddrb.org

Lancet

Related Cholera Articles from Brightsurf:

Potential cholera vaccine target discovered
Investigators at Massachusetts General Hospital analyzed antibodies recovered from humans who survived cholera.

Cause of 1990s Argentina cholera epidemic uncovered
The evolution of epidemic and endemic strains of the cholera-causing bacterium Vibrio cholerae in Argentina has been mapped in detail.

Microbiome confers resistance to cholera
Many parts of the world are in the midst of a deadly pandemic of cholera, an extreme form of watery diarrhea.

Cholera studies reveal mechanisms of biofilm formation and hyperinfectivity
Free-swimming cholera bacteria are much less infectious than bacteria in biofilms, aggregates of bacterial cells that form on surfaces.

Consuming cholera toxin counteracts age-associated obesity
Here the research team tested a safe and well-established microbe-based immune adjuvant to restore immune homeostasis and counteract inflammation-associated obesity in animal models.

The cholera bacterium can steal up to 150 genes in one go
EPFL scientists have discovered that predatory bacteria like the cholera pathogen can steal up to 150 genes in one go from their neighbors.

Research on cholera adds to understanding of the social life of bacteria
Strains of the bacterium Vibrio cholerae transform themselves from small, comma-shaped cells to long filaments in nutrient-poor environments to aid short-term survival.

The cholera bacterium's 3-in-1 toolkit for life in the ocean
The cholera bacterium uses a grappling hook-like appendage to take up DNA, bind to nutritious surfaces and recognize 'family' members, EPFL scientists have found.

Genetic code of WWI soldier's cholera mapped
The oldest publicly available strain of the cholera-causing bacterial species, Vibrio cholerae, has had its genetic code read for the first time.

Vaccine study confirms sensitivity of cholera test
Recently, the sensitivity of fecal microbiological cultures for detecting cholera has come under question.

Read More: Cholera News and Cholera Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.